|
|
|
|
|
|
|
|
|
|
|
| Category |
Science: Life_Sciences
|
|
|
|
|
|
|
|
|
|
|
|
| Description |
CBI’s Premier Public Policy Congress provides a forum for professionals within the pharmaceutical and biotech industry to discuss the changing political landscape of 2008 while addressing future impacts and challenges. Through extensive panel discussions and interactive sessions, this meeting will discuss:
• Discuss the federal election impact on U.S. healthcare policy reform
• Review the industry debate on Follow-On Biologics
• Analyze individual state approaches to healthcare reform
• Overcome key policy issues with performance incentives
• Understand Medicare Part B and D
• Manage the changing FDA
• Compare industry implications for comparative effectiveness
• Communicate effectively with government bodies
• Enhance corporate relations through a patient advocacy perspective
• Engage in effective grassroots strategy
• Evaluate the new Disclosure and Contribution Report
Plus! Hear Two Government Perspectives:
• Navigating the Democratic Agenda
And
• Navigating the Republican Agenda
|
|
|
|
